Table 1.
Screening Criteria Used to Identify Potential Transgender/Gender Nonbinary Patients
| ICD-9 and 10-CM codesa | Gender marker and medications | Keywords |
|---|---|---|
| 302.50: Trans-sexualism with unspecified sexual history 302.51: Trans-sexualism with asexual history 302.52: Trans-sexualism with homosexual history 302.53: Trans-sexualism with heterosexual history 302.85: Gender identity disorder in adolescents or adults F64.0: Transsexualism, transgender, gender dysphoria F64.1: Gender identity disorder in adolescence or adulthood F64.2: Gender identity disorder of childhood F64.8: Other gender identity disorders F64.9: Gender identity disorder, unspecified Z87.890: Personal history of sex reassignment |
Male gender marker and estrogens/progestins Estrogen or progesterone & spironolactone 200mg Estrogen or progesterone and finasteride Female gender marker and testosterone HIV funding-related variables Transgender on HIV care form Discrepant AIRSb sex and institutional EHR sex Discrepant AIRS sex assigned at birth and gender identity |
Gender dysphoria Gender non-conforming Gender transition Genderqueer Gender reassignment Female to male FTMc Male to female MTF Sex reassignment Transgender Transsexual Transvestite |
a
International Classification of Diseases, 9th and 10th Revisions, Clinical Modification codes
b
AIRS = New York State Department of Health AIDS Institute Reporting System – Includes data collection required for Ryan White HIV/AIDS Program grant funding
c
Eliminated prior to chart review